Vivos Inc (QB) (RDGL) Cotización

Yes it was. Fuc that criminal organization.

That's bold of them.

MMs still hard on the .12 brakes.

Whats up with that?

Liquidity and Capital Resources

At June 30, 2024, the Company had working capital of $1,603,105, as compared to working capital of $1,365,120 at December 31, 2023.

As of June 30, 2024, the Company has $1,724,417 cash on hand.

Yeah, they have plenty of cash for now

Very nice update!

Breakthrough radiation therapy for pets closes in on FDA clearance | Tri-Cities Area Journal of Business https://t.co/X3V1UXQS3m— Vivos Inc. (@VivosIncUSA) August 19, 2024

they had 1.7million cash end of Jun

Let's say max 10k a month for the isopet van.

I think they will be ok

They have an offering out, there can't be a private placement lined up.

Nice try on both counts

My guess is they have a private placement lined up to go through after the IDE approval

I'd file that one under something other than the "guess" category. Who wouldn't take them up on a after the fact opportunity such as that. Have they even been sincerely shopping the note around? (Kind of doubt it) Or is that an opportunity that was predestined that priority be given to a certain loyal investors group. Which I'm fine with by the way. Point is Dr. Korenko would have no issue lining up private placement once the IDE approval is complete.

From Korenko's post Friday it sounds like they have just recently sent off a response to at least one of the FDAs questions. With the BBD designation I think we should hear back from FDA in about a week

Update from the CEO regarding the ongoing discussions with the FDA. General updates will be posted on this platform as new information becomes available. Subscribe to our newsletter at https://t.co/FfgSTxpyrZ for important press releases for #RadioGel and #IsoPet $RDGL pic.twitter.com/1t2fJ1hcnS— Vivos Inc. (@VivosIncUSA) August 16, 2024




This update above comes, as will be the case with the FDA IDE resubmission PR imho, well after said fact occurred. Sounds like the FDA and Dr. Korenko aren't as far a part on solution as a certain individual would have liked for us to believe. The open market BUYS sure ramped up shortly after FDA interaction and dialog.I view that as a good sign. Who wouldn't?.....


08/13/2024*************** KORENKO MICHAEL K
Officer Direct Buy 0.1119 50,000

08/07/2024*************** KORENKO MICHAEL K
Officer Direct Buy 0.1176 50,000

08/01/2024*************** KORENKO MICHAEL K
Officer Direct Buy 0.0872 50,000



Matthew 12:38-39

38 Then certain of the scribes and of the Pharisees answered, saying, Master, we would see a sign from thee.

39 But he answered and said unto them, An evil and adulterous generation seeketh after a sign; and there shall no sign be given to it, but the sign of the prophet Jonas:

3 days in a whale.....nah couldn't be.....well.....nah.....never trust your gut but it would make a intriguing story. Everything I say is my own personal hypothesis and should not be interpreted as anything but.....tick tock

Load your boat now imo
Liftoff arriving ...imo

Seems like the IsoPet Van tour has stopped posting since a bit after the IDE delay. I wonder if they got called back until the IDE issue is resolved. Short-term cash reserves is an issue until we know what FDA wants. We really need the cash on hand to meet whatever needs they have as dilution would not be great right now. My guess is they have a private placement lined up to go through after the IDE approval.

We are almost half way through the 45 day window that Korenko estimated it would take to submit new IDE. From Korenko's post Friday it sounds like they have just recently sent off a response to at least one of the FDAs questions. With the BBD designation I think we should hear back from FDA in about a week. If that issue was addressed, and it was the only issue we would probably be re-submitting IDE just as the 45 day window expires.

MM’s will control this until approval now, other than anybody buying back in that panic sold. They position themselves every morning to block a run to 12s

Quiet here, quiet trading. Waiting for the other shoe to drop. At least we have our socks on.

$RDGL

Thanks Roofus. Appreciate your posts on here as well.

Makes sense to me. Hoping earlier, but that time-line is realistic.

Probably middle of October ….

Which is 75 days after the announcement we got on July 29 about having to re-submit the IDE.

Hello. Whats the new time frame for FDA approval? We looking at somewhere in early October or do we feel it could come sooner? Thanks.

Amen!

Exactly

Exactly what I have been saying about the rdgl treatment, that the naysayers have been indicating is old technology here that's bs.

Hopefully God's will be done on earth as it is in this human outpatient cancer treatment...

Let's roll rdgl and Mayo clinic with CEO DR KORENKO

Big Pharma's Mantra: A patient cured is a lifetime customer lost...

Big Pharma's probaby not liking that statement as well. It either put them on high alert to buy and die Radiogel or try squash them with other means. BP want nothing out there that permanently cures cancer. And Its probably why Vivos finds the back door to FDA always locked. Well see.

But yeah, bold statement by Doc. I like it.

I think it's a little risky saying something like that, but for Dr. K to say it as conservative as he is with everything makes me really bullish on the outlook.

That is so great to hear that Isopet is working like it should.

Radiogel will do amazing things for people after its approved. So close now...

Ivan is doing well thanks. At 12yrs old people are amazed at how youthful he looks and behaves. Looking forward to great things here and appreciate all your positive input.

That is huge that paragraph and thank you for sharing!

You're welcome!

Yeah, i remember your inputs on your travels up to Kennewick and Ivans procedure. He still doing good?


Isopet Van is in your area. Maybe you all will get a city clinic for any future pets cancer needs.

I particularly liked the very bottom paragraph by Doc.

“In oncology, they never say ‘cure,’ they say ‘life extension.’ But I’m here to say that our goal is to cure it,” Korenko said.

Seems to me you may be asking chat GPT (which I don't trust at all) questions that goes beyond the scope of what the FDA requested from VIVOS. I don't know why you harp on or wish for frivolous testing the FDA didn't ask? If the case is otherwise, don't you think VIVOS would have acknowledged that fact in the recent update? That smells like deceptive FUD to me. Also, what does it matter who contacted whom for an article? Was the article substantively and objectively on point? And if you have no issue with the overall point of the article (as you acknowledged), why harp on who contacted whom? An attempt at taking away from the overall point? Not an attack; just saying.

Very cool. I would like to know if the paper reached out to them or vice versa. Regardless its an awesome article. Fingers cross the FDA doesn't screw us over again.

The first question I asked ChatGPT and its answer
1. what is 'the sprint process' as it relates to FDA Breakthrough device program?
The "sprint process" within the FDA's Breakthrough Devices Program refers to a streamlined approach that the FDA uses to facilitate the development and review of breakthrough technologies. Specifically, it is designed to address specific scientific or regulatory issues more efficiently and collaboratively between the FDA and the device sponsor.
The sprint process is an example of how the FDA is working to adapt its regulatory processes to better support innovation while maintaining its commitment to safety and effectiveness.

The next question I asked based on the above answer was
2. So by definition if a device is undergoing the sprint process than an issue or challenge has been identified by the FDA?
Yes, if a device is undergoing the sprint process, it generally means that a specific issue or challenge has been identified that needs to be resolved to move the device's development or review forward. This issue could be identified by either the FDA or the device sponsor, but the sprint process is initiated to address it efficiently.

The sprint process is used to focus on and resolve these particular issues, which might be scientific, technical, or regulatory in nature. The goal is to quickly find a solution or reach an agreement on the path forward, so the overall development of the device can continue without significant delays.

Third question I asked based on above
3. Is the resolution typically positive or can the resolution involve need for additional testing?
ChatGPT said:
The resolution of issues addressed during the sprint process can vary depending on the nature of the problem and the information available. While the goal is to facilitate progress, the outcomes of the sprint process can include a range of possibilities:

Positive Resolution: In many cases, the sprint process results in a positive resolution where the issue is satisfactorily addressed, allowing the development process to move forward. This could involve the FDA agreeing with the sponsor's proposed approach or modifications that meet regulatory requirements.

Need for Additional Testing or Data: The sprint process can also lead to a resolution where the FDA determines that additional testing, data collection, or further study is required before the issue can be fully resolved. This outcome is common when the FDA believes that more evidence is needed to ensure the device's safety and effectiveness.

Modification of the Development Plan: Sometimes, the resolution might involve modifying the development plan for the device, such as changing the study design, adjusting the regulatory pathway, or revising the testing protocols.

Identification of New Issues: During the sprint process, other related issues might be identified that also need to be addressed. This can lead to a more comprehensive approach to resolving multiple challenges.

Overall, while the sprint process aims for a positive resolution that moves the project forward, it can also highlight the need for additional work, including further testing or data collection, to ensure that the device meets the necessary regulatory standards.

Fully agree with that, only wish I had more funds to buy more. GTLA and everyone have a great weekend.

That is a nice write up, thanks walnut. Kennewick is also were Ivan was treated.

nice summary, however, the conclusion “In summary, if dosimetry is a focus of the sprint process, it indicates that the FDA and the device sponsor are working to resolve issues related to the measurement or control of radiation doses, with a strong emphasis on accuracy, safety, and regulatory compliance” is incorrect as there is no indication of “issues needing to be resolved” — the FDA is merely requiring data

Crystal ball is RIGHT more than WRONG.....

the crystal ball isn't a slot machine. It's where gut instinct and good peripheral vision draws a most likely probable outcome.....




familyof5 Re: linkvest post# 178267
Friday, August 02, 2024 3:31:34 PM

In the last 5 days Korenko has made two separate 50,000 purchases. Significance of these last 2 stock buys are they come immediately right after FDA interaction. And first time he has ever done so in such a short time span.....8 weeks ago he purchased 50,000 shares. Could there be additional purchases in the coming days and weeks? This is the first time that I know of where he purchased shares on the open market with such frequency. He is one of only a very select few individuals who knows with a certainty what lose ends are left to satisfy the FDA request. And what is required to meet those expectations. Read into it what you will but there is a old biblical cliche that couldn't be any closer to the truth....."Your actions will always follow your beliefs" .....I anticipate we will be hearing more from him any day now in the not so distant future.....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174857250




familyof5 Re: WALLnut post# 178739
Tuesday, August 13, 2024 10:54:48 PM


THRICE in THREE+FIVE in TWO+SEVEN in TEN


08/13/2024*************** KORENKO MICHAEL K
Officer Direct Buy 0.1119 50,000

08/07/2024*************** KORENKO MICHAEL K
Officer Direct Buy 0.1176 50,000

08/01/2024 KORENKO MICHAEL K
Officer Direct Buy 0.0872 50,000

07/29/2024 KORENKO MICHAEL K
Officer Direct Buy 0.0935 50,000

06/04/2024 KORENKO MICHAEL K
Officer Direct Buy 0.1687 50,000

11/13/2023 KORENKO MICHAEL K
Officer Direct Buy 0.0517 100,000

10/18/2023 KORENKO MICHAEL K
Officer Direct Buy 0.0536 100,000



familyof5 Re: linkvest post# 178267
Friday, August 02, 2024 3:31:34 PM

In the last 5 days Korenko has made two separate 50,000 purchases. Significance of these last 2 stock buys are they come immediately right after FDA interaction. And first time he has ever done so in such a short time span.....8 weeks ago he purchased 50,000 shares. Could there be additional purchases in the coming days and weeks? This is the first time that I know of where he purchased shares on the open market with such frequency. He is one of only a very select few individuals who knows with a certainty what lose ends are left to satisfy the FDA request. And what is required to meet those expectations. Read into it what you will but there is a old biblical cliche that couldn't be any closer to the truth....."Your actions will always follow your beliefs" .....I anticipate we will be hearing more from him any day now in the not so distant future.....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174915925





********************************************************************************************************************




familyof5 Re: Truthsocial post# 178479
Thursday, August 08, 2024 3:50:32 PM

Wouldn't be hard to close green here as crazy at that sounds.....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174888926




familyof5 Re: familyof5 post# 178482
Thursday, August 08, 2024 4:05:53 PM

WOW! Mind blown! What a close .1144 UP 1.82% Thank you MM


https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/trades



familyof5 Re: Truthsocial post# 178479
Thursday, August 08, 2024 3:50:32 PM

Wouldn't be hard to close green here as crazy at that sounds.....15:50:17 0.1035 10,000

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174889074





familyof5 Re: familyof5 post# 178488
Thursday, August 08, 2024 4:40:58 PM

RDGL TRADING DATA 08/08/24 Last 10 Minutes

16:00:00 0.1144 5,000
15:59:57 0.11275 900
15:59:51 0.1143 5,000
15:59:42 0.111 5,000
15:59:38 0.111 8,900
15:59:36 0.1109 5,000
15:59:19 0.1082 5,000
15:59:05 0.110 400
15:59:05 0.10805 933
15:58:34 0.107165 16,878
15:58:23 0.1036 20,000
15:57:38 0.1036 43,700
15:57:37 0.1036 4,900
15:57:35 0.1036 5,000
15:57:34 0.10355 5,000
15:57:33 0.1036 2,500
15:57:29 0.104 8,900
15:57:27 0.104 50,000
15:57:24 0.1085 5,000
15:56:30 0.110 100
15:55:29 0.1085 8,900
15:55:08 0.10405 350
15:55:08 0.108455 26,500
15:50:55 0.1035 1,976
15:50:54 0.1035 4,124
15:50:54 0.1035 8,900
15:50:43 0.105 5,000
15:50:23 0.105 5,000
15:50:21 0.1035 5,000
15:50:19 0.1035 10,000
15:50:17 0.1035 10,000

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174889328





********************************************************************************************************************





familyof5 Re: familyof5 post# 178535
Friday, August 09, 2024 11:41:15 AM

Nah....probably not going to get those cheapies today. Probably will get another green close though so I'll take the trade off. Monday morning would be a good day to open up some FDA dialog. Yeah definitely be a good day to start having that discussion.....

Date********Close
9 Aug 2024 0.1175 0.0031 2.71% 0.115 0.1189 0.101666 859,328

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174893273



Update from the CEO regarding the ongoing discussions with the FDA. General updates will be posted on this platform as new information becomes available. Subscribe to our newsletter at https://t.co/FfgSTxpyrZ for important press releases for #RadioGel and #IsoPet $RDGL pic.twitter.com/1t2fJ1hcnS— Vivos Inc. (@VivosIncUSA) August 16, 2024

The process is progressing rather nicely so it seems. This update comes, as will be the case with the FDA IDE resubmission PR imho, well after said fact occurred. But who knows.....

After countless rabbit tests

I'm beginning to question the intelligence of the reviewers let alone integrity

Nice write up here..

Breakthrough radiation therapy for pets closes in on FDA clearance

https://www.tricitiesbusinessnews.com/articles/vivos

from ChatGPT:

If a device's sprint process involves dosimetry, it means that the issue or challenge being addressed relates to the measurement, calculation, or assessment of the dose of radiation absorbed by a person or an object, typically in the context of medical devices that use or measure radiation.

Specific Implications:
Radiation Safety: Dosimetry is critical in ensuring that medical devices that involve radiation (e.g., X-ray machines, radiation therapy devices, or imaging equipment) deliver the correct dose safely. The sprint process might focus on ensuring that the device accurately measures or controls radiation exposure to avoid under- or over-dosing.

Calibration and Validation: The sprint process might address the calibration, validation, or accuracy of the dosimetry function within the device. This could involve reviewing the methods used to calculate doses, verifying that the device delivers consistent and accurate measurements, and ensuring that it meets regulatory standards.

Regulatory Compliance: The sprint process may also focus on ensuring that the dosimetry aspects of the device comply with relevant FDA regulations and guidelines. This could include addressing any discrepancies or uncertainties related to dosimetry data or demonstrating that the device meets specific performance criteria.

Patient Safety: Ensuring proper dosimetry is vital for patient safety, particularly in devices used for radiation therapy, where the precise dose of radiation is critical for effective treatment while minimizing harm to surrounding tissues. The sprint process might aim to resolve any concerns about the accuracy or safety of the dosimetry features.

Development of New Dosimetry Technology: If the device involves innovative dosimetry technology, the sprint process might focus on validating this new approach, ensuring that it provides accurate and reliable measurements, and determining how it compares to existing standards.

In summary, if dosimetry is a focus of the sprint process, it indicates that the FDA and the device sponsor are working to resolve issues related to the measurement or control of radiation doses, with a strong emphasis on accuracy, safety, and regulatory compliance.

from Wikipedia: Medical dosimetry is the calculation of absorbed dose and optimization of dose delivery in radiation therapy. It is often performed by a professional health physicist with specialized training in that field. In order to plan the delivery of radiation therapy, the radiation produced by the sources is usually characterized with percentage depth dose curves and dose profiles measured by a medical physicist.

In radiation therapy, three-dimensional dose distributions are often evaluated using a technique known as gel dosimetry.

steady up she goes

VERY happy to see this update. Now we just have to wait for this process to play out.

The good Doc keeping us updated. Was hoping .12s with that tidbit tweet. Still, a nice finish for the week.

Update from the CEO regarding the ongoing discussions with the FDA. General updates will be posted on this platform as new information becomes available. Subscribe to our newsletter at https://t.co/FfgSTxpyrZ for important press releases for #RadioGel and #IsoPet $RDGL pic.twitter.com/1t2fJ1hcnS— Vivos Inc. (@VivosIncUSA) August 16, 2024

Dead cat bounce imo before crash

Rdgl is looking forward

If you want to see MMs in super mode.... check out NVDA on live L2. 100 mill shares traded in one hour.

MMs keep stacking up those Icebergs. But still a possibility today.

Just might break through .12 today.

Does crystal ball say what month this is supposed to happen in? I have quarters if thats what it takes to make it visionable to look into.

Ok time to look into my crystal ball and make a hypothetical prediction. There will be no pre-announcement prior to the FDA IDE resubmission. Dr. Korenko will PR after resubmission has taken place. It will be in an hour when least expected. Either AFTER MARKET CLOSE or PREMARKET OPEN the day of. Many will be caught off guard. There will be wailing and gnashing of teeth.....

Matthew 12:38 - 39

38 Then certain of the scribes and of the Pharisees answered, saying, Master, we would see a sign from thee.

39 But he answered and said unto them, An evil and adulterous generation seeketh after a sign; and there shall no sign be given to it, but the sign of the prophet Jonas:

By the way.....I'm not here to makes friends.....I already have PLENTY.....

Who cares how often he posts, he’s been in this before Doctor K took over. Some of us true longs 9 plus years don’t feel the need to post a dozen times a day. Or even once a day. Especially now.

The company is in pre sub they could submit any day now. anyone that’s actually done their own DD knows this. As for the noise, that’s exactly what it is noise.

If you think for 1 second I am EVER happy to the price go down, you are wrong.

Anyone here who considers me a basher just know that I criticize for what I see as missteps by our CEO. I want this company to succeed more than most of you here, I know that.